BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28123544)

  • 1. Molecular heterogeneity in the novel fusion gene
    Okuda T; Taki T; Nishida K; Chinen Y; Nagoshi H; Sakakura C; Taniwaki M
    Oncol Lett; 2017 Jan; 13(1):215-221. PubMed ID: 28123544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26.
    Katoh M; Katoh M
    Int J Oncol; 2003 May; 22(5):1155-9. PubMed ID: 12684685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes.
    Mendoza S; David H; Gaylord GM; Miller CW
    Cancer Genet Cytogenet; 2005 Apr; 158(2):142-7. PubMed ID: 15796961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line.
    Guillaud-Bataille M; Brison O; Danglot G; Lavialle C; Raynal B; Lazar V; Dessen P; Bernheim A
    Cytogenet Genome Res; 2009; 124(1):1-11. PubMed ID: 19372663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44-SLC1A2 fusion transcripts in primary colorectal cancer.
    Shinmura K; Kato H; Igarashi H; Inoue Y; Nakamura S; Du C; Kurachi K; Nakamura T; Ogawa H; Tanahashi M; Niwa H; Sugimura H
    Pathol Oncol Res; 2015 Jul; 21(3):759-64. PubMed ID: 25576211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16).
    Zhang Y; Zeleznik-Le N; Emmanuel N; Jayathilaka N; Chen J; Strissel P; Strick R; Li L; Neilly MB; Taki T; Hayashi Y; Kaneko Y; Schlegelberger B; Rowley JD
    Genes Chromosomes Cancer; 2004 Nov; 41(3):257-65. PubMed ID: 15334549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
    Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
    Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a complex genomic alteration on chromosome 2p that leads to four alternatively spliced fusion transcripts in the neuroblastoma cell lines IMR-5, IMR-5/75 and IMR-32.
    Oberthuer A; Skowron M; Spitz R; Kahlert Y; Westermann F; Mehler K; Berthold F; Fischer M
    Gene; 2005 Dec; 363():41-50. PubMed ID: 16216448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel DNA sequences at chromosome 10q26 are amplified in human gastric carcinoma cell lines: molecular cloning by competitive DNA reassociation.
    Mor O; Messinger Y; Rotman G; Bar-Am I; Ravia Y; Eddy RL; Shows TB; Park JG; Gazdar AF; Shiloh Y
    Nucleic Acids Res; 1991 Jan; 19(1):117-23. PubMed ID: 2011492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets.
    Akasaka T; Akasaka H; Yonetani N; Ohno H; Yamabe H; Fukuhara S; Okuma M
    Genes Chromosomes Cancer; 1998 Jan; 21(1):17-29. PubMed ID: 9443038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.
    Mizuno S; Hanamura I; Ota A; Karnan S; Kanasugi J; Nakamura A; Takasugi S; Uchino K; Horio T; Goto M; Murakami S; Gotou M; Yamamoto H; Watarai M; Shikami M; Hosokawa Y; Miwa H; Taniwaki M; Ueda R; Nitta M; Takami A
    FEBS Open Bio; 2018 Dec; 8(12):1977-1991. PubMed ID: 30524948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data.
    Hoogstrate Y; Komor MA; Böttcher R; van Riet J; van de Werken HJG; van Lieshout S; Hoffmann R; van den Broek E; Bolijn AS; Dits N; Sie D; van der Meer D; Pepers F; Bangma CH; van Leenders GJLH; Smid M; French PJ; Martens JWM; van Workum W; van der Spek PJ; Janssen B; Caldenhoven E; Rausch C; de Jong M; Stubbs AP; Meijer GA; Fijneman RJA; Jenster GW
    Gigascience; 2021 Dec; 10(12):. PubMed ID: 34891161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
    Holzmann K; Kohlhammer H; Schwaenen C; Wessendorf S; Kestler HA; Schwoerer A; Rau B; Radlwimmer B; Döhner H; Lichter P; Gress T; Bentz M
    Cancer Res; 2004 Jul; 64(13):4428-33. PubMed ID: 15231651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
    Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
    Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.
    Haralambieva E; Schuuring E; Rosati S; van Noesel C; Jansen P; Appel I; Guikema J; Wabinga H; Bleggi-Torres LF; Lam K; van den Berg E; Mellink C; van Zelderen-Bhola S; Kluin P
    Genes Chromosomes Cancer; 2004 May; 40(1):10-8. PubMed ID: 15034863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors.
    Heiskanen M; Kononen J; Bärlund M; Torhorst J; Sauter G; Kallioniemi A; Kallioniemi O
    Anal Cell Pathol; 2001; 22(4):229-34. PubMed ID: 11564899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
    Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
    Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts.
    Narita M; Shimizu K; Hayashi Y; Taki T; Taniwaki M; Hosoda F; Kobayashi H; Nakamura H; Sadamori N; Ohnishi H; Bessho F; Yanagisawa M; Ohki M
    Br J Haematol; 1999 Jun; 105(4):928-37. PubMed ID: 10554802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15.
    Quade BJ; Weremowicz S; Neskey DM; Vanni R; Ladd C; Dal Cin P; Morton CC
    Cancer Res; 2003 Mar; 63(6):1351-8. PubMed ID: 12649198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.